We are Epilepsy Society. The UK’s only charity transforming the lives of people with epilepsy through world-leading research, advocacy and care.
Care services
We are the leading charity care provider, where people love to work and live. Our wide range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Medical services
The Chalfont Centre and our Gowers unit lead the way in the most advanced techniques for the diagnosis and treatment of epilepsy.
Campaigns
Our campaigns team lobby government and decision-makers on the issues that matter to people with epilepsy. From safer medicines for pregnant women to the dangers of online trolling, and from medicines supply to public transport access, we raise awareness of the daily challenges facing people with epilepsy.
Latest news
Medication update
We have been informed by Teva UK that Zonisamide 25/50/100mg is currently out of stock.
New family GPs must be trained in epilepsy, says the Epilepsy Society
The Epilepsy Society has welcomed government plans to bring back the family doctor, promising greater continuity of care for people with long-term health conditions. And it has offered help to ensure that GPs receive better training in epilepsy so that they can fully support those with the condition.
Olympic rower James Cracknell backs Epilepsy Society call to Keir Starmer to fix the medicines supply chain
Epilepsy Society has asked Prime Minister Keir Starmer for an early Christmas present - a review of the medicines supply chain. In the last year many people with epilepsy have struggled to get their life-saving medication because of problems with medication shortages.
COVID-19 vaccination programme for Spring 2025
The Government has announced the COVID-19 vaccination programme for Spring 2025.
Epilepsy medicine manufacturers fined for charging excessive prices
Pfizer and Flynn Pharma, manufacturers of phenytoin sodium capsules which are used to treat epilepsy, have been fined a combined total of £69 million by the Competitions Appeal Tribunal (CAT) for “charging excessive prices” between 2012 and 2016.
Royal Pharmaceutical Society (RPS) report calls on the Government to create a national strategy to manage medication shortages
Epilepsy Society welcomes the report from RPS, Medicines Shortages: solutions for empty shelves which calls on the Government to create a national strategy to manage medication shortages.
Our research
Research
The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.
Genomics
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
Therapeutic Drug Monitoring (TDM)
Therapeutic drug monitoring (TDM) is an area of clinical chemistry that specialises in measuring medication levels (concentrations) in patients, usually through blood samples but also through saliva samples.
You can call our helpline on 01494 601 400.
We're open:
Monday and Wednesday - 9am to 7.30pm
Tuesday, Thursday, and Friday - 9am to 4pm
Saturday - 9am to 12.30pm
You can also reach us by email
helpline@epilepsysociety.org.uk.